focus trial semaglutide Ozempic maker Novo Nordisk says it will study drug's effects on alcohol consumption but isn't focused on addiction Semaglutide, central retinal thickness and

"Alpha lipoic acid for symptomatic peripheral neuropathy in patients with diabetes: a meta-analysis of randomized controlled trials." Int J Endocrinol

For those with insurance that covers GLP-1 medications, it may be worth comparing what a plan would cover for an FDA-approved version at a retail pharmacy versus the platform's cash-pay pricing for compounded versions

Current GLP-1 treatments for obesity consist of daily or weekly injectable medications that come with drawbacks, including the need for cold chain distribution and storage, risk of injection site reactions, and needle-related discomfort

The oral Wegovy 25 mg pill was approved in December 2025